DrugPatentWatch Database Preview

LEVO-T Drug Profile

« Back to Dashboard

When do Levo-t patents expire, and what generic alternatives are available?

Levo-t is a drug marketed by Cediprof Inc and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in LEVO-T is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Summary for LEVO-T

US Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	19
Bulk Api Vendors:	84
Patent Applications:	4,198
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for LEVO-T
DailyMed Link:	LEVO-T at DailyMed

Pharmacology for LEVO-T

Ingredient-type	Thyroxine
Drug Class	l-Thyroxine

Synonyms for LEVO-T

(-)-Thyroxine

(-)-Thyroxine Sodium

(125I)T4

(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid

(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic aci d, sodium salt

(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid

(S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid

(S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionic Acid Sodium Salt

002T595

054I36CPMN

137-53-1

1hk1

1hk2

1hk3

1hk4

1hk5

1y0x

2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid

24486-40-6

25416-65-3

2ceo

3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine

3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine

3,3?,5,5?-Tetraiodo-L-thyronine sodium salt

3,3',5,5'-Tetraiodo-L-thyronine

3,3',5,5'-Tetraiodo-L-thyronine Sodium

3,3',5,5'-Tetraiodo-L-thyronine sodium salt

3,3',5,5'-Tetraiodo-L-thyronine, sodium salt

3,3',5,5''-Tetraiodo-L-thyronine

3,3',5,5"-Tetraiodo-L-thyronine

3,3'',5,5''-tetraiodo-L-thyronine

3,5,3',5'-Tetraiodo-L-thyronine

3,5,3',5'-Tetraiodothyronine

3,5,3'',5''-tetraiodo-L-thyronine

3,5,3'5'-Tetraiodo-L-thyronine

4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine

50809-32-0

51-48-9

55-03-8

587-29-1

587-30-4

60833-83-2

6260AF

67809-22-7

7200-84-2

74-16-8

7488-70-2

7U4LEE5872

A830452

AB00052176_09

AB00052176_10

AB00052176-08

AB0010528

AB2000689

AC-10210

AC-10465

AC-7504

AC-919

AC1L1L7K

AK-40208

AK-46618

AKOS015905129

AKOS015918420

AKOS024284731

AM006672

AM016770

AM83594

AN-15421

AN-8921

API0007805

AX8015809

BBC/815

BC204258

BC630681

BDBM50301375

Berlthyrox

beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine

BIDD:PXR0161

bmse000923

BPBio1_000360

BRD-K30685142-001-05-5

BRN 2228515

BSPBio_000326

BSPBio_002142

C01829

C08212

C15H10I4NO4.Na

C15H11I4NO4

CAS-51-48-9

CCG-38738

CCRIS 6739

CHEBI:18332

CHEBI:6446

CHEMBL1624

CHM0030272

CPD000059176

CS-1819

CT-230

CT-452

CTK2H7538

CTK4J3191

D-3,5-Diiodo-4-(3',5'-Diiodo-4'-hydroxyphenoxy)-phenylalanine sodium salt

D06RGG

D08125

Dathroid

DB-006261

DB00451

DivK1c_006967

DL-Thyroxin

DSSTox_CID_3214

DSSTox_GSID_23214

DSSTox_RID_76927

DTXSID8023214

EBD2201200

Eferox

EINECS 200-101-1

EINECS 200-221-4

eltroxin

Eltroxin (TN)

Epitope ID:123889

Epitope ID:136776

Euthyrox

Euthyrox (TN)

Eutirox

Eutirox (TN)

Forthyron

Forthyron (TN)

FT-0600821

FT-0628030

FT-0658959

GP9966

GTPL2635

Henning

Henning Sodium

HMS1569A08

HMS1921I06

HMS2090P18

HMS2092K12

HMS2096A08

HMS2233J18

HMS3259M11

HSDB 3108

HY-18341

I14-8105

J-524276

J10324

KB-53412

KBio1_001911

KBio2_001556

KBio2_004124

KBio2_006692

KBio3_001642

KBioGR_000516

KBioSS_001556

KS-00000F9R

KS-00000HDI

L-3,5,3',5'-Tetraiodothyronine

L-T4

L-T4 Sodium

L-Thryoxin

L-Thyroxin

L-Thyroxin Sodium

L-thyroxine

L-Thyroxine (T4) solution, 100 mug/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material

L-thyroxine (TN)

l-Thyroxine monosodium salt

L-Thyroxine sodium

L-Thyroxine sodium salt

L-Thyroxine, >=98% (HPLC)

L-Thyroxine, free acid

L-Thyroxine, powder, BioReagent, suitable for cell culture

L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-

L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt

L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, hydrate (9CI)

L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1)

Laevothyroxinum

Laevothyroxinum (acid)

Laevoxin

Letter

Levaxin

Levaxin (TN)

Leventa

Levolet

Levoroxine

levothroid

Levothroid (*Sodium salt*)

Levothroid (*Sodiumsalt*)

Levothyrox

Levothyroxin

levothyroxin natrium

Levothyroxin-natrium

levothyroxine

Levothyroxine (BAN)

Levothyroxine [INN]

Levothyroxine sodique

Levothyroxine sodique [INN-French]

Levothyroxine sodium

Levothyroxine Sodium (anhydrous)

Levothyroxine Sodium (L-thyroxine)

Levothyroxine Sodium [USAN:INN]

Levothyroxine Sodium [USAN]

Levothyroxine sodium anhydrous

levothyroxine sodium pentahydrate

Levothyroxine sodium tablets

Levothyroxine, pharmaceutical secondary standard; traceable to USP, PhEur

Levothyroxine, United States Pharmacopeia (USP) Reference Standard

Levothyroxinum

Levothyroxinum (acid)

Levothyroxinum natricum

Levothyroxinum natricum [INN-Latin]

levotiroxina de sodio

Levotiroxina sodica

Levotiroxina sodica [INN-Spanish]

Levoxyl

Levoxyl (TN)

LS-153817

LS-153822

LS-158291

LT00440967

LT4

MFCD00002595

MLS000028647

MLS002548901

MolPort-002-511-861

MolPort-003-666-820

Monosodium L-thyroxine

NC00485

NCGC00094852-03

NCGC00164336-01

NCGC00164336-02

NCGC00164336-03

NCGC00164336-05

NCGC00255368-01

Novothyrox

NSC 259940

NSC 36397

NSC 36397-Sodium

NSC-757434

NSC757434

O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine

O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine

O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine Sodium

O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine

Oroxine

Pharmakon1600-01500774

Prestwick_548

Prestwick0_000403

Prestwick1_000403

Prestwick2_000403

Prestwick3_000403

Q51BO43MG4

RL03895

RL04067

Ro-thyroxine

Roxstan

s2599

SAM002264651

SBI-0051608.P002

SCHEMBL23098

SCHEMBL34102

SDCCGMLS-0066571.P001

SMR000059176

sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate

sodium (2S)-2-azanyl-3-[4-[3,5-bis(iodanyl)-4-oxidanyl-phenoxy]-3,5-bis(iodanyl)phenyl]propanoate

Sodium (S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionate

sodium 4-o-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine

Sodium l-thyroxin

Sodium L-thyroxine

Sodium levothyroxine

SODIUM LEVOTHYROXINE(1-)

Sodium thyroxin

Sodium thyroxinate

Sodium thyroxine

Sodium-L-thyroxine

Sodiumlevothyroxine

Soloxine

SPBio_000386

SPBio_002265

SpecPlus_000871

Spectrum_001076

SPECTRUM1500774

Spectrum2_000573

Spectrum3_000611

Spectrum4_000128

Spectrum5_001500

ST078859

ST24047479

STOCK1N-15023

synthroid

Synthroid (*Sodium salt*)

Synthroid (TN)

Synthroid sodium

T-3850

t4

T4 (Hormone)

T4 levothyroxine

T4 Sodium

T44

Tetraiodothyronine

Tetramet

Tetroid

Thevier

Thryroxine, l-

THX

Thyradin

Thyradin S

Thyratabs

Thyrax

Thyrax (TN)

Thyrax Sodium

Thyreoideum

Thyreoideum Sodium

Thyro-Tabs

THYROID

Thyronamin

Thyrosit

Thyrox (TN)

Thyroxevan

thyroxin

Thyroxin sodium

Thyroxinal

Thyroxinal Sodium

thyroxine

Thyroxine (l)

Thyroxine (T4), IRMM(R) certified Reference Material

Thyroxine (VAN)

Thyroxine [BAN]

Thyroxine I 125

Thyroxine iodine

Thyroxine sodique

Thyroxine sodium

Thyroxine sodium salt

Thyroxine, L-

Thyroxine, L- (8CI)

Thyroxine, L-(8CI)

Thyroxine, labeled with iodine-125

Thyroxine, monosodium salt, L-

Thyroxinique

Thyroxinum natricum

Tiroidina

Tirosint

Tirosint-Sol

Tox21_112101

Tox21_112101_1

Tox21_302156

TR-031344

Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, labeled with iodine-125

Tyrosint

UNII-054I36CPMN

UNII-7U4LEE5872

UNII-Q51BO43MG4

UNII-QR0BV3BRIA component XUIIKFGFIJCVMT-LBPRGKRZSA-N

Unithroid

XUIIKFGFIJCVMT-LBPRGKRZSA-N

YDTFRJLNMPSCFM-YDALLXLXSA-M

Z2798529463

ZINC3830993

US Patents and Regulatory Information for LEVO-T

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-001	Mar 1, 2002	AB1,AB2,AB3	RX	Yes	No
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-007	Mar 1, 2002	AB1,AB2,AB3	RX	Yes	No
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-004	Mar 1, 2002	AB1,AB2,AB3	RX	Yes	No
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-011	Mar 1, 2002	AB1,AB2,AB3	RX	Yes	Yes

International Patents for LEVO-T

Country	Document Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	0174448
Australia	5295301
Israel	152024
Brazil	0109736